Seth Martin Selected Research

Seth Martin Research Topics

3	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 09/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020 - 01/2020
1	COVID-19 10/2020
1	Infections 10/2020
1	Heart Failure 10/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Liposarcoma 04/2018
1	Shock 04/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 04/2018
1	Abdominal Aortic Aneurysm 02/2017
1	Rhabdomyolysis 11/2016
1	Stroke (Strokes) 11/2016
1	Myocardial Infarction 11/2016
1	Muscular Diseases (Myopathy) 11/2016
1	Vascular Diseases (Vascular Disease) 11/2016
1	Diabetes Mellitus 11/2016
1	Myalgia 11/2016
1	Dyslipidemias (Dyslipidemia) 11/2013
1	Insulin Resistance 11/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2013

2	LipidsIBA 10/2020 - 01/2020
2	HDL CholesterolIBA 01/2020 - 11/2013
2	C-Reactive ProteinIBA 01/2020 - 11/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 11/2016
2	LDL CholesterolIBA 01/2020 - 11/2016
2	Lipoprotein(a)IBA 02/2017 - 09/2015
1	vupanorsenIBA 10/2020
1	Colchicine FDA LinkGeneric 10/2020
1	Antihypertensive Agents (Antihypertensives)IBA 10/2020
1	eicosapentaenoic acid ethyl esterIBA 10/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020
1	Angiotensin Receptor AntagonistsIBA 10/2020
1	empagliflozinIBA 10/2020
1	CholesterolIBA 01/2020
1	ApolipoproteinsIBA 01/2020
1	alpha Adrenergic ReceptorsIBA 04/2018
1	Enoxaparin (Lovenox)FDA LinkGeneric 04/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2016
1	Atorvastatin (Lipitor)FDA Link 11/2016
1	Triglycerides (Triacylglycerol)IBA 11/2013
1	EnzymesIBA 11/2013